Loading...
A dose response study to assess the effects of New Zealand Pine Bark extract on glycaemic responses in healthy participants.
A dose response study to assess the effects of New Zealand Pine Bark extract on glycaemic responses in healthy participants.
Abstract
Background: The current estimation of 451 million people diagnosed with diabetes is expected to increase to 693 million by 2045. Plant extracts have been shown to improve glycaemic control in humans. However, evidence is lacking regarding the hypoglycaemic effects of New Zealand pine bark obtained from Pinus radiata trees.
Type
Conference Contribution
Type of thesis
Series
Citation
Lim, W. X. J., von Hurst, P., Gammon, C., Chepulis, L. M., & Page, R. (2019). A dose response study to assess the effects of New Zealand Pine Bark extract on glycaemic responses in healthy participants. In Proceedings (Vol. 8, pp. 52–52). Auckland, New Zealand.
Date
2019
Publisher
Degree
Supervisors
Rights
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).